In a world first, Canadian scientists at the CRCHUM, the hospital research center affiliated with Université de Montréal, ...

Recurrent lupus nephritis pathology in the kidney transplant may not appear the same as previous disease in the native kidney.

Two urine metabolites of the choline oxidation pathway — choline and dimethylglycine — can independently predict risks for ...

The following is a summary of “Sodium-glucose cotransporter-2 inhibitor therapy improves renal and hepatic function in patients with cirrhosis secondary to metabolic dysfunction associated steatotic ...

Kidney fibrosis, a common endpoint of chronic kidney disease (CKD), is strongly linked to aging, with cellular senescence ...

Over half a million people visit emergency rooms each year due to kidney stone complications. An estimated one in ten individuals experiences kidney stones at some point in their lives.

Here’s the catch: kidney damage doesn’t usually scream for attention in the early stages. It creeps up silently, showing subtle signs only when things have already taken a turn for the worse.

Novartis has agreed to buy Regulus Therapeutics for up to $1.7 billion, giving the Swiss drugmaker access to an experimental drug to treat a life-threatening kidney disease.

The researchers found that 37.7% received a deceased donor kidney allograft, 14.7% received a living donor allograft, 7.4% died while on the waiting list, 12.7% were removed, and 27.5% were still ...

Early kidney damage often shows subtle signs like foamy urine, swelling, and increased nighttime urination. Fatigue, ...